ORIGINAL RESEARCH
Published on 16 Apr 2025
Dual targeting of EZH2 and PD-L1 in Burkitt’s lymphoma enhances immune activation and induces apoptotic pathway
doi 10.3389/fimmu.2025.1578665
- 137 views
- Frontiers in Hematology
- Blood Cancer
- Research Topics
- New molecular targets for personalized treatment for Low-Grade Non-Hodgkin Lymphoma
New molecular targets for personalized treatment for Low-Grade Non-Hodgkin Lymphoma
1,119
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.